
How Industry and Regulatory Innovation and Collaboration Can Promote the Transition From in Vivo to in Vitro Potency Testing for Human Legacy Vaccines

Speaker Presentation: WCBP 2025
Coppens Emmanuelle, Sanofi, 2025
How Industry and Regulatory Innovation and Collaboration Can Promote the
Transition From in Vivo to in Vitro Potency Testing for Human Legacy Vaccines